Evaluation of an extensively hydrolysed casein formula (Damira 2000) in children with allergy to cow's milk proteins.
Allergol Immunopathol (Madr). 2010 Mar-Apr;38(2):60-8. doi: 10.1016/j.aller.2009.08.001. Epub 2009 Dec 16.
Allergol Immunopathol (Madr). 2010.
PMID: 20015589
Clinical Trial.
OBJECTIVE: To assess the allergenic capacity of a new extensively hydrolysed casein formula (Damira 2000) in vivo in children with allergy to cow's milk, and to conduct an immunochemical evaluation of the product. ...
OBJECTIVE: To assess the allergenic capacity of a new extensively hydrolysed casein formula (Damira 2000) in vivo in children with al …